PORTAL DE PRODUCCIÓN CIENTÍFICA - UAM
  • Idioma
    • Español
    • Inglés
  • acceder

» iPublic » Perfil del investigador


MARTIN VENTURA, JOSE LUIS

iMarina ID: 04-261698
Códigos de identificación
Departamento Universitario
Medicina.
Universidad Autónoma de Madrid.
Ciudad Universitaria de Cantoblanco. Madrid. 28049
Centro
Facultad de Medicina.
Universidad Autónoma de Madrid.
Ciudad Universitaria de Cantoblanco. Madrid. 28049
Grupo
Laboratorio De Remodelado Vascular.
Universidad Autónoma de Madrid.
Ciudad Universitaria de Cantoblanco. Madrid. 28049
Área de Conocimiento
Medicina

Formación Académica

  • Timeline
Timeline
diciembre de 2003
Doctorado: DOCTOR/A
Universidad Autónoma de Madrid
enero de 2003
Doctorado: Doctor/a
Universidad Autónoma de Madrid

Trayectoria Profesional

  • Reconocimientos Docentes
  • Reconocimientos Investigación
  • Timeline
Reconocimientos Docentes

Quinquenios


2
Año último Quinquenio: 2018
Reconocimientos Investigación

Sexenios

3
Año último Sexenio: 2016

Timeline
diciembre de 2018
Coordinador/a
Universidad Autónoma de Madrid. Laboratorio De Remodelado Vascular

   2018 -

noviembre de 2013
Profesor Contratado Doctor LOU
Universidad Autónoma de Madrid. Medicina

   2013 -

diciembre de 2008
Ramón y Cajal. Medicina
Universidad Autónoma de Madrid

   2008 - 2013

febrero de 2008
Titulado superior. Medicina
Universidad Autónoma de Madrid

   2008 - 2008

Doctorado
Universidad Autónoma de Madrid

   2003 -

Transferencia e impacto social

  • Publicaciones en Altmetrics
  • Fuente de impacto, otros
Publicaciones en Altmetrics
2020Complement C5 Protein as a Marker of Subclinical Atherosclerosis
2020Macrophage cholesterol efflux downregulation is not associated with abdominal ao...
2019Pathophisiology of abdominal aortic aneurysm: biomarkers and novel therapeutic t...
2019A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty res...
2019Role of complement system in pathological remodeling of the vascular wall
2019APOA1 oxidation is associated to dysfunctional high-density lipoproteins in huma...
2018Combination of biomarkers of vascular calcification and sTWEAK to predict cardio...
2018Potential role of insulin receptor isoforms and IGF receptors in plaque instabil...
2018Impaired HDL (High-Density Lipoprotein)-Mediated Macrophage Cholesterol Efflux i...
2018Lipocalin-2, a potential therapeutic target in advanced atherosclerosis
2018Arachidonic Acid, but Not Omega-3 Index, Relates to the Prevalence and Progressi...
2017Increased galectin-3 levels are associated with abdominal aortic aneurysm progre...
2017Oxidative stress in human atherothrombosis: Sources, markers and therapeutic tar...
2017Association of ficolin-3 with abdominal aortic aneurysm presence and progression
2017The Application of Proteomic Techniques in the Study of HDL Particle Characteriz...
2017TWEAK blockade decreases atherosclerotic lesion size and progression through sup...
2017Soluble TWEAK and atheromatosis progression in patients with chronic kidney dise...
2016Plasma levels of monocyte chemoattractant protein-1, n-terminal fragment of brai...
2016Lipocalin-2 deficiency or blockade protects against aortic abdominal aneurysm de...
2016Proteomics and metabolomics in biomarker discovery for cardiovascular diseases: ...
2016Vascular Proteomics
2016ANGPTL4 deficiency in haematopoietic cells promotes monocyte expansion and ather...
2016Soluble TWEAK and major adverse cardiovascular events in patients with CKD
2016Parathormone levels are independently associated with the presence of left ventr...
2016A Single In-Vial Dual Extraction Strategy for the Simultaneous Lipidomics and Pr...
2016Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybr...
2016Quantitative HDL Proteomics Identifies Peroxiredoxin-6 as a Biomarker of Human A...
2016Down-regulation of Fibulin-5 is associated with aortic dilation: Role of inflamm...
2016Paraoxonase-1 overexpression prevents experimental abdominal aortic aneurysm pro...
2015Biomarkers and predictive models for abdominal aortic aneurysm growth [Estudio d...
2015N-terminal pro-brain natriuretic peptide is associated with a future diagnosis o...
2015Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression ...
2015The Prognostic Value of High-Sensitive Troponin I in Stable Coronary Artery Dise...
2015Impact of plasma pro-B-type natriuretic peptide amino-terminal and galectin-3 le...
2015Hemoglobin induces monocyte recruitment and CD163-macrophage polarization in abd...
2015Targeted gold-coated iron oxide nanoparticles for CD163 detection in atheroscler...
2015Differential profile in inflammatory and mineral metabolism biomarkers in patien...
2015TWEAK/Fn14 interaction promotes oxidative stress through NADPH oxidase activatio...
2015Atorvastatin inhibits the atherosclerotic lesion induced by tumor necrosis facto...
2015Soluble TWEAK levels predict the presence of carotid atherosclerotic plaques in ...
2015Thioredoxin-1/peroxiredoxin-1 as sensors of oxidative stress mediated by NADPH o...
2015ApoA-I/HDL-C levels are inversely associated with abdominal aortic aneurysm prog...
2014Tumor necrosis factor-like weak inducer of apoptosis or fn14 deficiency reduce e...
2014Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, a...
2014Assessment of Biomarkers and Predictive Model for Short-term Prospective Abdomin...
2014Label-free quantitative proteomic analysis of human plasma-derived microvesicles...
2014Pathology of human plaque vulnerability: Mechanisms and consequences of intrapla...
2014RNA binding protein HuR regulates the expression of ABCA1
2014Galectin-3, a biomarker linking oxidative stress and inflammation with the clini...
2014Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosi...
2014Tumor necrosis factor-like weak inducer of apoptosis or Fn14 deficiency reduce e...
2014From tissue iron retention to low systemic haemoglobin levels, new pathophysiolo...
2014Label-free proteomic analysis of red blood cell membrane fractions from abdomina...
2013Soluble TWEAK is associated with atherosclerotic burden in patients with chronic...
2013Impaired high-density lipoprotein anti-oxidant capacity in human abdominal aorti...
2013Statin use in aortic aneurismal disease to prevent progression and cardiovascula...
2013Proteomic analysis of intraluminal thrombus highlights complement activation in ...
2013HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in ather...
2013Unraveling biomarkers of abdominal aortic aneurisms by iTRAQ analysis of deplete...
2013Identification of novel biomarkers of abdominal aortic aneurysms by 2D-DIGE and ...
2013HDL and endothelial protection
2012Erythrocytes, leukocytes and platelets as a source of oxidative stress in chroni...
2012HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosc...
2012Metabolomics with LC-QTOF-MS permits the prediction of disease stage in aortic a...
2012Oxidative stress in cardiovascular pathologies: Genetics, cellular, and molecula...
2012From intraplaque haemorrhages to plaque vulnerability: Biological consequences o...
2012Cell stress proteins in atherothrombosis.
2012Increased plasma levels of NGAL, a marker of neutrophil activation, in patients ...
2012Plasma profiling by a protein array approach identifies IGFBP-1 as a novel bioma...
2012Metabolomic study of plasma of patients with abdominal aortic aneurysm
2011TWEAKFn14 interaction enhances plasminogen activator inhibitor 1 and tissue fact...
2011Metabolites secreted by human atherothrombotic aneurysms revealed through a meta...
2011Insulin-like growth factor i - A novel biomarker of abdominal aortic aneurysms
2011Diagnostic and therapeutic strategies for small abdominal aortic aneurysms
2011Induction of macrophage chemotaxis by aortic extracts from patients with marfan ...
2011CCL20 Is Increased in Hypercholesterolemic Subjects and Is Upregulated By LDL in...
2011Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans
2011Proteomic analysis of polymorphonuclear neutrophils identifies catalase as a nov...
2011Animal Models of Cardiovascular Diseases
2011Soluble TWEAK plasma levels predict expansion of human abdominal aortic aneurysm...
2011Vascular proteomics and the discovery process of clinical biomarkers: The case o...
2011Targeted and non-targeted metabolic time trajectory in plasma of patients after ...
2011Study of the capillary electrophoresis profile of intact α-1-acid glycoprotein i...
2011Identification of peroxiredoxin-1 as a novel biomarker of abdominal aortic aneur...
2011Impact of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortal...
2010Combined therapy with renin-angiotensin system and calcium channel blockers in t...
2010Heat shock protein 90 inhibitors attenuate inflammatory responses in atheroscler...
2010Local Non-Esterified Fatty Acids Correlate With Inflammation in Atheroma Plaques...
2010TWEAK soluble, un nuevo biomarcador de riesgo cardiovascular
2010Peripheral artery disease is associated with a high CD163/TWEAK plasma ratio
2010Increased levels of thioredoxin in patients with abdominal aortic aneurysms (AAA...
2010Proteomic strategies in the search of new biomarkers in atherothrombosis
2010Proteomic and metabolomic profiles in atherothrombotic vascular disease
2009Plasma fingerprinting with GC-MS in acute coronary syndrome
2009HDL antielastase activity prevents smooth muscle cell anoikis, a potential new a...
2009Cardiovascular Risk and Antiangiogenic Therapy for Age-related Macular Degenerat...
2009The MIF Receptor CD74 in Diabetic Podocyte Injury
2009Search for Serum Biomarkers Associated with Abdominal Aortic Aneurysm Growth - A...
2009Leukotriene B4 enhances the activity of nuclear factor-κB pathway through BLT1 a...
2009The proteomic approach in the development of prognostic biomarkers in atherothro...
2009Biomarkers in Cardiovascular Medicine
2009Las proteínas de choque térmico (heat shock proteins) como potenciales dianas te...
2009Respuesta
2009Increased CD74 expression in human atherosclerotic plaques: contribution to infl...
2009New mediators implicated in atherogenesis
2009Suppressors of Cytokine Signaling Modulate JAK/STAT-Mediated Cell Responses Duri...
2009Soluble TWEAK plasma levels as a novel biomarker of endothelial function in pati...
2009The CD163-expressing macrophages recognize and internalize TWEAK. Potential cons...
2009Vascular proteomics, a translational approach: From traditional to novel proteom...
2009Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular a...
2009Improving metabolite knowledge in stable atherosclerosis patients by association...
2009Considering TWEAK as a target for therapy in renal and vascular injury
2009Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis ...
2008Plasma concentration of heat shock protein 27 and risk of cardiovascular disease...
2008Adiponectin plasma levels are increased by atorvastatin treatment in subjects at...
2008Proteomics in atherosclerosis
2008Effect of Intensive Atorvastatin Therapy on Prostaglandin E2 Levels and Metallop...
2008Atorvastatin decreases elevated soluble CD40L in subjects at high cardiovascular...
2008Treatment with amlodipine and atorvastatin has additive effect on blood and plaq...
2008LDL induces parathyroid hormone-related protein expression in vascular smooth mu...
2008Soluble Fas ligand plasma levels are associated with forearm reactive hyperemia ...
2007Characterization of the human atheroma plaque secretome by proteomic analysis
2007TWEAK and Fn14. New players in the pathogenesis of atherosclerosis
2007Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (...
2007TRAIL and vascular injury
2007Ethanol beverages containing polyphenols decrease nuclear factor kappa-B activat...
2007Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk ...
2007Pleiotropic effects of telmisartan in diabetic patients
2007Mechanisms of action of statins in stroke
2007Low plasma levels of HSP70 in patients with carotid atherosclerosis are associat...
2007Increased soluble Fas plasma levels in subjects at high cardiovascular risk: Ato...
2007Proteomics in atherothrombosis: a future perspective
2007Etanol beverages containing polyphenols decrease nuclear factor kappa-B activati...
2007Atorvastatin modulates the profile of proteins released by human atherosclerotic...
2006Losartan improves resistance artery lesions and prevents CTGF and TGF-beta produ...
2006Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is e...
2006Atorvastatin reduces the expression of prostaglandin E2 receptors in human carot...
2006Retention and Activation of Blood-Borne Proteases in the Arterial Wall. Implicat...
2006Plasminogen activation: A mediator of vascular smooth muscle cell apoptosis in a...
2006Overexpression of COX-2, Prostaglandin E Synthase-1 and Prostaglandin E Receptor...
2006Biological significance of decreased HSP27 in human atherosclerosis
2006Biology of atherosclerotic plaques: What we are learning from proteomic analysis
2006Vascular protection of dual therapy (atorvastatin-amlodipine) in hypertensive pa...
2005HMG-CoA reductase inhibitors reduce IκB kinase activity induced by oxidative str...
2005Quest for novel cardiovascular biomarkers by proteomic analysis
2005Inflammatory biomarkers and statins
2005Proteomic approach in the search of new cardiovascular biomarkers
2005Intensive treatment with atorvastatin reduces inflammation in mononuclear cells ...
2004Intensive treatment with statins and the progression of cardiovascular diseases:...
2004Butter and walnuts, but not olive oil, elicit postprandial activation of nuclear...
2004NF-κB Activation and Fas Ligand Overexpression in Blood and Plaques of Patients ...
2004Statins in hypertensive patients: Potential explanations for the ASCOT-LLA study...
2004Identification by a differential proteomic approach of heat shock protein 27 as ...
2004Decreased circulating Fas ligand in patients with familial combined hyperlipidem...
2003Anti-inflammatory and immunomodulatory effects of statins
2003Proteomic analysis of human vessels: Application to atherosclerotic plaques
2003Simvastatin reduces NF-kappa B activity in peripheral mononuclear and in plaque ...
20033-Hydroxy-3-methylglutaryl coenzyme a reductase inhibitors decrease Fas ligand e...
2003Possible role of parathyroid hormone-related protein as a proinflammatory cytoki...
2003Atorvastatin diminishes Fas ligand expression in atherosclerotic plaques and blo...
2002Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of ath...
Fuente de impacto, otros

Altmetrics

Publicaciones en redes sociales: 6 / 33
Porcentaje:18.18%
Puntuación:
27.35
Puntuación media:
27.35/33=0.829

Publicaciones

  • Publicaciones
  • Indicadores bibliométricos
  • Visibilidad
  • Temáticas más frecuentes
Publicaciones

Total de Publicaciones:185

179

Artículos | Reviews

6

Libros

Indicadores bibliométricos

Indice H


44
Scopus (2021-01-11)

Citas


5802
Scopus (2021-01-11)

Porcentaje en Q1

Porcentaje en D1


Visibilidad

Presencia en bases de datos


173
Scopus (2021-01-11)
19
Dialnet(2021-01-15)
Temáticas más frecuentes
Temáticas

Congresos

  • País de la actividad
  • Congresos
País de la actividad
Congresos

Total de Congresos : 0

Proyectos

  • Proyectos participados
Proyectos participados

Dirección y participación en proyectos

IP

NO IP

Grupos, Redes

  • Grupos, Redes
Grupos, Redes

Laboratorio De Remodelado Vascular

Docencia

  • Asignatura / Curso
  • Actividad docente
Asignatura / Curso

Actividad docente

Tesis Dirigidas


7

Centros


  • Universidad Autónoma de Madrid

Resultados y actividad

  • Resultados y actividad
Resultados y actividad
Título:
Autores:
Afiliación:
Fuente:
Disciplina:
Palabras clave:
Indicios de calidad:
id ítem Tipo Año IF (JCR) IF (SJR)
id ítem Tipo Año IF(JCR) IF(SJR)

Colaboración

  • Colaboración institucional últimos 5 años
Colaboración institucional últimos 5 años
iMarina Information Systems Consulting Information Systems Consulting iMarina © 2021.
Legal term
Soporte técnico: ihelp@scimarina.com
El CVN se está generando. Este proceso puede tardar unos minutos, espere que termine el procedimiento completo o la descarga del CVN se iterrupirá. Recuerde que si dispone de un curriculum extenso la exportación del pdf puede llegar a tardar un tiempo considerable. Cualquier problema en la descarga contacte con oficina técnica de iMarina.
Hubo un problema al generar su report, por favor, inténtelo de nuevo más tarde.